Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751971 · ClinicalTrials.gov registry record · NA
Estimating Apnea Phenotypes From Polysomnography: Oxygen
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT01751971 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 47 participants.
The verdict
NCT01751971, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study seeks to employ advanced methods to estimate the individual factors contributing to sleep apnea from standard recordings made during routine clinical sleep studies. This study focuses on breathing control or "loop gain" as one of the factors contributing to sleep apnea. Increased levels of oxygen in the air is known to make breathing more stable by lowering "loop gain". Here, our goal is to use a new method capable of detecting a reduction in loop gain with oxygen. The investigators also aim to test whether a high loop gain measured at baseline/placebo predicts a greater improvement in sleep apnea with oxygen therapy.
Interventions
- OTHER Sham
- DRUG Inspired oxygen (40%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751971
The ClinicalTrials.gov registry entry for NCT01751971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT01751971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751971 about?
NCT01751971 is a clinical study titled "Estimating Apnea Phenotypes From Polysomnography: Oxygen". This study seeks to employ advanced methods to estimate the individual factors contributing to sleep apnea from standard recordings made during routine clinical sleep studies. This study focuses on breathing control or "loop gain" as one of the factors contributing to sleep apnea. Increased levels o...
What is the current status of trial NCT01751971?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2012-11. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01751971?
The interventions under investigation include: Sham (OTHER), Inspired oxygen (40%) (DRUG).
Who is sponsoring clinical trial NCT01751971?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.